Literature DB >> 20624752

Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Arielle W Tolman1, Matthew M Kurtz.   

Abstract

Quality of life (QOL) has been recognized as a crucial domain of outcome in schizophrenia treatment, and yet its determinants are not well understood. Recent meta-analyses suggest that symptoms have only a modest relationship to QOL (Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007;33:1225-1237). Individuals with schizophrenia show 1-2 SD deficits on measures of elementary neurocognition, and links between these deficits and objective measures of community functioning (eg, employment and independent living) are well established. While objective measures of community functioning and measures of QOL would appear to be closely related, studies investigating the ability of neurocognitive variables to predict QOL in individuals with schizophrenia have yielded conflicting results. One potential explanation for opposing findings in the schizophrenia literature is the interchangeable use of objective and subjective indices of QOL. This study used quantitative methods of meta-analysis to clarify the relationship between neurocognitive determinants of objective QOL (ie, observable, clinician-rated) and subjective QOL (ie, patient satisfaction) separately in individuals with schizophrenia. A total of 20 studies (10 objective and 10 subjective) consisting of 1615 clients were aggregated from relevant databases. Weighted effect size analysis revealed that there were small-moderate relationships (d ≤ 0.55) between crystallized verbal ability, working memory verbal list learning, processing speed, and executive function and objective indices of QOL. In contrast, results revealed either nonsignificant or inverse relationships for the vast majority of neurocognitive measures and measures of subjective QOL. Moderating variables and implications for future research and treatment development are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20624752      PMCID: PMC3283161          DOI: 10.1093/schbul/sbq077

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  Neurocognitive and social functioning in schizophrenia.

Authors:  J Addington; D Addington
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

2.  The way in which intervention studies have "personality" and why it is important to meta-analysis.

Authors:  M W Lipsey; D B Wilson
Journal:  Eval Health Prof       Date:  2001-09       Impact factor: 2.651

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

5.  A critical appraisal of the quality of quality-of-life measurements.

Authors:  T M Gill; A R Feinstein
Journal:  JAMA       Date:  1994 Aug 24-31       Impact factor: 56.272

6.  Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem?

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Victoria Irzhevsky; Christina M Kitchen; Stephanie M Woo; Jim Mintz
Journal:  Schizophr Res       Date:  2005-01-20       Impact factor: 4.939

Review 7.  Cognitive impairment in schizophrenia is the core of the disorder.

Authors:  B Elvevåg; T E Goldberg
Journal:  Crit Rev Neurobiol       Date:  2000

8.  Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates.

Authors:  F B Dickerson; N B Ringel; F Parente
Journal:  Acta Psychiatr Scand       Date:  1998-08       Impact factor: 6.392

9.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.

Authors:  D W Heinrichs; T E Hanlon; W T Carpenter
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

10.  Social cognition in schizophrenia: an overview.

Authors:  David L Penn; Lawrence J Sanna; David L Roberts
Journal:  Schizophr Bull       Date:  2008-03-28       Impact factor: 9.306

View more
  51 in total

1.  When functional capacity and real-world functioning converge: the role of self-efficacy.

Authors:  Veronica Cardenas; Stephanie Abel; Christopher R Bowie; Denisse Tiznado; Colin A Depp; Thomas L Patterson; Dilip V Jeste; Brent T Mausbach
Journal:  Schizophr Bull       Date:  2012-02-10       Impact factor: 9.306

2.  Does the Psychiatrist's Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient's Well-Being Perception than Clinical Judgement Alone?

Authors:  Warut Aunjitsakul; Teerapat Teetharatkul; Arnont Vitayanont; Tippawan Liabsuetrakul
Journal:  Adm Policy Ment Health       Date:  2021-03-17

3.  Perceptions of health intervene in the relationship between psychiatric symptoms and quality of life for individuals in supportive housing.

Authors:  Jason Matejkowski; Sungkyu Lee; Benjamin Henwood; Jonathon Lukens; Lara Carson Weinstein
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

4.  Determinants of Employment Outcome for the People with Schizophrenia Using the WHODAS 2.0.

Authors:  Shu-Jen Lu; Tsan-Hon Liou; Chia-Feng Yen; Feng-Hang Chang; Yen-Ling Chen; Reuben Escorpizo; David R Strauser; Ay-Woan Pan
Journal:  J Occup Rehabil       Date:  2019-06

5.  Neural correlates of global and specific cognitive deficits in schizophrenia.

Authors:  Robert J Jirsaraie; Julia M Sheffield; Deanna M Barch
Journal:  Schizophr Res       Date:  2018-06-25       Impact factor: 4.939

6.  Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Tara Kingston; Paul J Scully; David J Browne; Patrizia A Baldwin; Anthony Kinsella; Eadbhard O'Callaghan; Vincent Russell; John L Waddington
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

7.  The clinical characterization of the patient with primary psychosis aimed at personalization of management.

Authors:  Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

8.  Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Authors:  Deanna M Barch; Julia M Sheffield
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

9.  Self-efficacy and functional status in schizophrenia: relationship to insight, cognition and negative symptoms.

Authors:  Matthew M Kurtz; Rachel H Olfson; Jennifer Rose
Journal:  Schizophr Res       Date:  2013-02-01       Impact factor: 4.939

10.  Disrupted prefrontal interhemispheric structural coupling in schizophrenia related to working memory performance.

Authors:  Anne L Wheeler; M Mallar Chakravarty; Jason P Lerch; Jon Pipitone; Zafiris J Daskalakis; Tarek K Rajji; Benoit H Mulsant; Aristotle N Voineskos
Journal:  Schizophr Bull       Date:  2013-07-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.